Showing results (1431-1440 of 3,717) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|August 3, 2013
Bcl-2 antagonists: a proof of concept for CLL therapyKumudha Balakrishnan, Varsha Gandhi
Investigational New Drugs|June 11, 2013
Cardiac glycosides in cancer therapy: from preclinical investigations towards clinical trialsM Slingerland, C Cerella, H J Guchelaar, et al.
Investigational New Drugs|June 13, 2013
Phase I clinical trial of lenalidomide in combination with sorafenib in patients with advanced cancerPrasanth Ganesan, Sarina Piha-Paul, Aung Naing, et al.
Investigational New Drugs|June 4, 2013
Rhodamine-marked bombesin: a novel means for prostate cancer fluorescence imagingAlexander Sturzu, Sumbla Sheikh, Hartmut Echner, et al.
Investigational New Drugs|March 8, 2013
Phase I clinical and pharmacokinetic study of trabectedin and cisplatin given every three weeks in patients with advanced solid tumorsCristiana Sessa, Gianluca Del Conte, Alexandre Christinat, et al.
Investigational New Drugs|June 27, 2013
Cediranib in combination with fulvestrant in hormone-sensitive metastatic breast cancer: a randomized Phase II studyDavid M Hyams, Arlene Chan, Celia de Oliveira, et al.
Investigational New Drugs|March 30, 2013
A phase I schedule dependency study of the aurora kinase inhibitor MSC1992371A in combination with gemcitabine in patients with solid tumorsE Raymond, J Alexandre, S Faivre, et al.
Investigational New Drugs|June 7, 2012
A preclinical and clinical study of mycophenolate mofetil in pancreatic cancerJ Rodríguez-Pascual, P Sha, E García-García, et al.
Investigational New Drugs|June 5, 2012
Phase I study of barasertib (AZD1152), a selective inhibitor of Aurora B kinase, in patients with advanced solid tumorsGary K Schwartz, Richard D Carvajal, Rachel Midgley, et al.
Investigational New Drugs|May 15, 2012
Investigation of bendamustine HCL in a phase 2 study in women with resistant ovarian cancerAmanda F Baker, Denise J Roe, Cynthia Laughren, et al.
Pageof 372